Expression of FSCN1 and FOXM1 are associated with poor prognosis of adrenocortical carcinoma patients.
Jiayu LiangZhihong LiuXin WeiLiang ZhouYongquan TangChuan ZhouKan WuFuxun ZhangFan ZhangYiping LuYuchun ZhuPublished in: BMC cancer (2019)
These results show that FSCN1 and FOXM1 are independent prognostic factors in ACCs and over-expression of FSCN1 or FOXM1 indicates a worse prognosis.